Impact of metabolic syndrome on re-stenosis development: role of drug-eluting stents
{{output}}
Metabolic syndrome (MetS) is defined as a cluster of numerous cardiovascular risk factors, which encompasses obesity, dyslipidaemia, insulin resistance and hypertension. Patients with MetS are more prone to developing cardiovascular events than other patients.... ...